Khatija Ali

BioSapien, Inc. is a company that offers a joint solution to the problems of surgery and chemotherapy. The company is based in New York, NY. The company's technology, medichip™, is a delivery platform designed to deliver drugs directly onto a local site, with an initial indication for treating locally advanced unresectable tumor(s). The company aims to reduce patient burden and decrease patient non-compliance caused by the serious side effect profile of systemic chemotherapy. The company was founded by Khatija Ali, who has been the CEO since incorporation.